d2 | D3 | D4, 5 | DU | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Compliance group (n = 101) | Non-compliance group (n = 101) | Absolute standardized difference, % | Compliance group (n = 65) | Non-compliance group (n = 65) | Absolute standardized difference, % | Compliance group (n = 38) | Non-compliance group (n = 38) | Absolute standardized difference, % | Compliance group (n = 38) | Non-compliance group (n = 38) | Absolute standardized difference, % | |
Age (years) | 81.9 ± 8.5 | 82.4 ± 8.2 | 5.9 | 82.4 ± 8.6 | 81.8 ± 10.8 | 6.1 | 80.8 ± 12.0 | 80.3 ± 11.9 | 4.2 | 78.2 ± 11.0 | 77.6 ± 14.3 | 4.7 |
Sex (male) (%) | 53.4 | 55.4 | 4.4 | 52.3 | 49.2 | 4.4 | 31.6 | 39.5 | 9.8 | 47.4 | 47.4 | 0 |
Hemoglobin (g/dL) | 10.7 ± 2.1 | 10.9 ± 2.0 | 9.8 | 10.3 ± 1.9 | 10.4 ± 1.7 | 5.5 | 10.2 ± 2.1 | 10.3 ± 1.5 | 5.5 | 10.1 ± 2.0 | 10.3 ± 1.8 | 5.3 |
Albumin (g/dL) | 2.9 ± 0.6 | 2.9 ± 0.6 | 0 | 2.6 ± 0.5 | 2.6 ± 0.6 | 0 | 2.6 ± 0.7 | 2.6 ± 0.7 | 0 | 2.6 ± 0.6 | 2.6 ± 0.6 | 9.8 |
DESIGN-R score at baseline | 8.6 ± 4.4 | 8.2 ± 4.5 | 8.9 | 14.7 ± 7.7 | 15.1 ± 6.5 | 5.6 | 25.9 ± 11.4 | 25.0 ± 9.8 | 8.5 | 21.5 ± 8.4 | 22.1 ± 7.0 | 7.8 |
Observational period (day) | 23.9 ± 21.1 | 22.6 ± 21.5 | 6.1 | 46.6 ± 53.4 | 42.1 ± 38.5 | 9.6 | 66.3 ± 47.2 | 63.3 ± 45.8 | 7.1 | 49.0 ± 61.5 | 45.1 ± 42.3 | 7.4 |
Locations | ||||||||||||
Sacrum | 39 | 47 | 23 | 26 | - | 20 | 22 | - | 11 | 15 | - | |
Coccyx | 14 | 7 | - | 5 | 4 | - | 1 | 3 | - | 2 | 2 | - |
Greater trochanter | 7 | 8 | - | 7 | 4 | - | 2 | 1 | - | 8 | 4 | - |
Heel | 9 | 12 | - | 11 | 7 | - | 3 | 1 | - | 7 | 10 | - |
Ilium | 3 | 6 | - | 3 | 5 | - | 1 | 2 | - | 2 | 2 | - |
Others | 29 | 21 | - | 16 | 19 | - | 11 | 9 | - | 8 | 5 | - |